NIPRUSS

This brand name is authorized in Austria, Finland, Israel, Lithuania, Turkey

Active ingredients

The drug NIPRUSS contains one active pharmaceutical ingredient (API):

1 Nitroprusside UNII EAO03PE1TC - SODIUM NITROPRUSSIDE

The principal pharmacological action of nitroprusside is relaxation of vascular smooth muscle and consequent dilation of peripheral arteries and veins. Other smooth muscle (e.g. uterus, duodenum) is not affected. Nitroprusside is more active on veins than on arteries. Read about Nitroprusside

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02DD01	Nitroprusside	C Cardiovascular system → C02 Antihypertensives → C02D Arteriolar smooth muscle, agents acting on → C02DD Nitroferricyanide derivatives
Discover more medicines within C02DD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 485398
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8817
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1014777
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699587751072